Works matching IS 21986576 AND DT 2023 AND VI 10 AND IP 3
Results: 19
Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 757, doi. 10.1007/s40744-023-00544-2
- By:
- Publication type:
- Article
Hospitalization Among Pulmonary Arterial Hypertension Patients With and Without Connective Tissue Disease Comorbidities Prescribed Oral Selexipag.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 741, doi. 10.1007/s40744-023-00547-z
- By:
- Publication type:
- Article
A Narrative Review of Acthar Gel for the Treatment of Myositis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 523, doi. 10.1007/s40744-023-00545-1
- By:
- Publication type:
- Article
Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 729, doi. 10.1007/s40744-023-00543-3
- By:
- Publication type:
- Article
Clinical Presentation and Treatment of Juvenile Idiopathic Arthritis Combined with Lung Disease: A Narrative Review.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 507, doi. 10.1007/s40744-023-00542-4
- By:
- Publication type:
- Article
Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 693, doi. 10.1007/s40744-023-00541-5
- By:
- Publication type:
- Article
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 635, doi. 10.1007/s40744-023-00540-6
- By:
- Publication type:
- Article
A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 615, doi. 10.1007/s40744-023-00539-z
- By:
- Publication type:
- Article
Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 649, doi. 10.1007/s40744-023-00538-0
- By:
- Publication type:
- Article
The Clinical Characteristics of Psoriatic Arthritis: A Cross-Sectional Study Based on the Psoriatic Arthritis Cohort of West China Hospital.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 775, doi. 10.1007/s40744-023-00537-1
- By:
- Publication type:
- Article
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 679, doi. 10.1007/s40744-023-00536-2
- By:
- Publication type:
- Article
Psoriatic Arthritis in Males and Females: Differences and Similarities.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 589, doi. 10.1007/s40744-023-00535-3
- By:
- Publication type:
- Article
Trends in Hospitalization for Tuberculosis and Other Opportunistic Infections in Australian Patients with Inflammatory Joint Diseases.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 563, doi. 10.1007/s40744-023-00534-4
- By:
- Publication type:
- Article
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 659, doi. 10.1007/s40744-023-00533-5
- By:
- Publication type:
- Article
Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 551, doi. 10.1007/s40744-023-00532-6
- By:
- Publication type:
- Article
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 707, doi. 10.1007/s40744-022-00519-9
- By:
- Publication type:
- Article
Patient Experience of Sjögren's Disease and its Multifaceted Impact on Patients' Lives.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 601, doi. 10.1007/s40744-023-00531-7
- By:
- Publication type:
- Article
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 575, doi. 10.1007/s40744-022-00523-z
- By:
- Publication type:
- Article
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 3, p. 539, doi. 10.1007/s40744-022-00521-1
- By:
- Publication type:
- Article